Esketamine

Esketamine Nasal Spray from Lori Calabrese, MD | The Ketamine Blog

We provide these articles about esketamine nasal spray, known by the brand name Spravato, to inform… and explain the similarities and differences between esketamine and ketamine, the compound esketamine was derived from. 

Racemic Ketamine and Its Twin Molecules

As a compound made of two mirror-image molecules, racemic ketamine performs with extraordinary and robust antidepressant strength. We call those mirror-image molecules enantiomers. So, the word “racemic” simply means a compound made of right-handed and left-handed molecules.

You probably notice that identical twins look not so much exactly the same, but rather, they look like mirror images of each other. This phenomenon occurs all through nature. And you see it on the cell level, too.

The fact that these molecules are mirror images of each other doesn’t mean they’re identical.  They’re similar…and have similar properties. Sometimes you see this with identical twins. For instance, one twin shows empathy, compassion, and introversion, while the other fills a room with laughter and friendliness.

In the same way, these molecules act differently also, with one showing stronger properties of one kind and the other showing stronger properties of another. It’s the synergy between the two that creates the characteristics of the full racemic compound.

The ketamine compound dynamically illustrates this. Each enantiomer behaves in some ways like the other, and behaves differently from the other in other ways.

We recognize the left enantiomer molecule s-ketamine…”s” being an abbreviation for the latin term for “left.” We recognize the right one r-ketamine, which is much easier to remember, right? So, with this in mind, they created a name that uses the “s” or the “r” phonetically.  So these enantiomers enjoy the nicknames of esketamine and arketamine. Clever-ish…maybe?

Creating a NEW Medicine with an Old Molecule

Researchers hoped that by separating the left mirror-image molecule from the right-side one, they could produce an antidepressant with fewer side effects and less addiction risk. They knew they needed an entirely new compound. Because they needed the financial benefits of a patent to pay for the extensive research and testing that would be required to receive FDA approval.

It turned out that their new medicine required the aide of a newly initiated anti-depressant to perform as an antidepressant effectively. But with that antidepressant added, it showed some promising ability for erasing suicidal thinking and lifting depression. 

Unfortunately, life in the laboratory behaves a lot like life everywhere else. It can be unpredictable. During the trials required for FDA approved, esketamine performed like a champ in some trials, and failed rather miserably in others.

At a time when the suicide rate rises higher and higher, psychiatrists need medicines that erase suicidal thinking. As a result, the FDA approved this new medicine along with its specially designed spray in March 2019. They took precautions, however.

They imposed safeguards. One such safeguard required that doses be restricted to administration in the office under medical supervision. Another one required that the doctor hold the patient for observation in the office for 2 hours after each dose, in case of side effects.

 A Ketamine-Derived Medicine Covered  by Insurance?

Janssen, a company owned by Johnson&Johnson which developed this medicine, promises that esketamine nasal spray will be covered by insurance. So, we’re waiting to hear what the coverage will be.

Will Spravato replace IV ketamine treatment?  Probably not.

While esketamine may not be as effective as ketamine and is more expensive to administer. Does it have a place in treatment of depression and suicidal thinking? We certainly hope so. The fact that insurance companies plan to provide coverage for it will hopefully make it available to patients who find IV ketamine treatment is out of reach financially.

Because of the way the media promoted Spravato (esketamine), most people think that ketamine nasal spray was approved by the FDA.  Esketamine isn’t ketamine, but it IS derived from ketamine. It performs with some of ketamine’s traits, but not others.

At Innovative Psychiatry, we embrace treatments that may help. And we hope esketamine will help some who haven’t been helped by traditional antidepressants or anxiety medicines. As you read these articles about esketamine nasal spray, remember this is a new medication and we’ll know more as we use it to treat the conditions it’s been developed to relieve.

Feeling Alienated? Some Form of Support Could be Helpful

Feeling alienated by abuse? Abuse can lead to depression but ketamine can help.

Kyle and Rose felt fighting hot rage at their parents for separating.  Kyle was 17 and Rose was 15. How could their parents be so selfish?? They had ripped apart the home that Kyle and Rose needed. Relied on. Their parents were so buried in their own demands and accusations of each other, they were […]

Continue Reading

Spravato: Esketamine Nasal Spray Controversy Storms Ahead

Spravato esketamine nasal spray can relieve depression in some people.

Have you tried Spravato? Periodically, we’ve added our two cents to the discussion. Since its approval by the FDA in March of last year, we’ve seen a variety of protests from psychiatrists about its value for treating treatment resistant and severe depression. A recent article published in The Lancet provides an overview of the back […]

Continue Reading

Student Need for Psychiatric Care on Campus Quadrupled

Mason hides away in the library because he's depressed, and student need for psychiatric care is too great to get help.

Mason walked to the student union and plopped down to drink his coffee. Man, he just wasn’t feeling it. He went to class, but the studying and note taking, and researching all year was getting to him. He just wanted to go to bed and stay there. Just another example of student need for psychiatric […]

Continue Reading

Relieve the Heartbreak of Elderly Depression with IV Ketamine

The heartbreak of elderly depression can leave hands idle and a big heart with nothing to do.

Ruby’s daughter let herself in with her key at the back door. When she walked in, the house was dark. Strange…she thought. Her mom was usually home on Saturdays.  She quietly stepped through the house looking for some sign of her mom.  A grave sense of dread came over her as the house continued to […]

Continue Reading

Fighting Meanness, Hatred, and Cyberbullying in Schools

Social media use can be good or destructive to teen users.

We recently talked about the prominence of depression in teen girls. And the fact that it’s rising at a faster rate than depression in teen boys. We also talked about the impact of social media on growing and developing preteens and teens. But let’s talk a little more about the meanness and bullying that is […]

Continue Reading

Why is Depression in Teen Girls Increasing So Fast??

Depression in teen girls is sometimes hard to identify, but social media has been a contributing factor.

Juliette stopped in her tracks. She could see from halfway down the hall that her locker had been trashed. Covered with photos, markings, and fake blood, it looked like a crime scene. As she got closer, she could see printed photos someone had taken of her while she was dressing in P.E. She ran to […]

Continue Reading

Can Use of Opioids Lead to PTSD? And If So, What Can You Do?

You know how a disorder – like bipolar disorder or PTSD – can make you so miserable…even make you want to self-medicate?   Doing so is rarely a good idea, though it may seem at the time that it helps.  But that’s for another post. Anyway, you know how self-medicating often accompanies these disorders, and […]

Continue Reading

Ketamine and Other Breakthroughs in Psychiatry for 2019

Man on a cell phone demonstrates one of the breakthroughs in Psychiatry of 2019.

Tomorrow is the last day of 2019…and the day before a new year – and a new decade – begins. Let’s jump in and look back. Let’s celebrate our progress over the last year and consider the impact of new breakthroughs this year. Some of these breakthroughs in psychiatry for 2019 may surprise you. The […]

Continue Reading

error: Content is protected !!